Saturday, Oct 12, 2024
HomeLegal Information (Page 2)

November 14 is World Diabetes Day, and a great opportunity for diabetes patients to consider the increased risk of bladder cancer associated with the drug Actos. Patients interested in alternatives to Actos should consult with their physicians to explore other options. Taking Actos or the generic

Read More

Late last year Novartis announced termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment; 8,609 patients from 36 countries were involved. There was an increased incidence after 18-24 months of non-fatal stroke, kidney complications, hyperkalemia (high potassium levels) and hypotension

Read More